CINETIQUE Translations
Cinetique Translations began as a one-woman operation in 2002 in Manchester (UK) when Laurence Auffret, a lecturer in translation at the University of Manchester and a qualified biologist, decided to combine her two areas of expertise: languages and life sciences. With an initial focus on the European market, the company’s first lines of business included training, management and language services for a variety of clients, including conducting training programmes for science students participating in Erasmus exchange programmes, acting as public relations manager for a number of international artists, managing cultural programmes and preparing Material Safety Data Sheets and labels for laboratory materials used in the French medical industry.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Atlas Translations Ltd
With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Company Details
Latest Content from PMHub
Supporting our team with an award-winning mental health strategy
Press Releases | June 26, 2026 | Mednet
Mental health has been at the centre of our business since our inception. But that work doesn't just extend to our client projects. Find out more about our award-winning mental...
The value: why localisation pays off across global trials
White Papers and Resources | June 26, 2026 | Cuttsy + Cuttsy
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026
Press Releases | June 24, 2026 | Genesis Research Group
Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Press Releases | June 23, 2026 | Medscape Education
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...
Designing Pharma Stands That People Actually Want to Step Onto
Press Releases | June 18, 2026 | Apex Events and Exhibitions
Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a stand that invites meaningful engagement...
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
White Papers and Resources | June 18, 2026 | Inizio
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
The solution: Good localisation doesn’t feel translated
White Papers and Resources | June 18, 2026 | Cuttsy + Cuttsy
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Good Patient Partnership Guide 2026: Patient Journey Mapping with the Patient Community
White Papers and Resources | June 18, 2026 | Precision AQ
Patient insight gathering and journey mapping can inform and enhance decision making and initiatives across life sciences. The Good Patient Partnership Guide 2026 brings together practical guidance, real world examples...
Healthcare information is becoming easier to access. Trust isn’t.
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.